In 2016, a team of investigators made a significant discovery regarding the expression of miR-30a in peripheral blood CD4+ T lymphocytes of individuals with MS and mice EAE: this study revealed that there was a significant reduction in the expression of miR-30a in these subjects. Here, CD4 is linked to myeloid sarcoma.